Mary Anne Dellva Selected Research

Major Depressive Disorder (Major Depressive Disorders)

5/2016	Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
6/2015	Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
1/2015	Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder.
1/2014	A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
6/2011	A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder.
4/2010	A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary Anne Dellva Research Topics

Disease

8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2024 - 10/2020
6	Major Depressive Disorder (Major Depressive Disorders) 05/2016 - 04/2010
4	Type 2 Diabetes Mellitus (MODY) 11/2023 - 12/2020
3	Injection Site Reaction 01/2023 - 10/2020
2	Nausea 01/2014 - 04/2010
2	Psychotic Disorders (Schizoaffective Disorder) 04/2010 - 08/2007
2	Schizophrenia (Dementia Praecox) 04/2010 - 08/2007
1	Hyperhidrosis 01/2014
1	Erectile Dysfunction 01/2014
1	Fatigue 01/2014
1	Pain (Aches) 01/2014
1	Bipolar Disorder (Manic Depressive Psychosis) 04/2010
1	Constipation 04/2010
1	Dementia (Dementias) 04/2010
1	Headache (Headaches) 04/2010
1	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2010
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2007

Drug/Important Bio-Agent (IBA)

11	Insulin Lispro (Humalog)FDA Link 01/2024 - 10/2020
6	alpha- ((5- fluoro- 2- methoxyphenyl)methyl)- alpha- (tetrahydro- 2H- pyran- 4- yl)- 2- morpholinemethanolIBA 05/2016 - 04/2010
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2016 - 04/2010
4	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 10/2020
4	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2016 - 01/2014
2	Antidepressive Agents (Antidepressants)IBA 06/2015 - 01/2015
1	Insulin (Novolin)FDA Link 01/2024
1	SuspensionsIBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 11/2023
1	Olanzapine (Zyprexa)FDA Link 04/2010
1	Antipsychotic Agents (Antipsychotics)IBA 08/2007
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 03/2007

Therapy/Procedure

2	Therapeutics 05/2016 - 06/2015
1	Injections 11/2023
1	Duration of Therapy 08/2007